August 6, 2020
The FDA has announced two voluntary recalls on Metformin:
- On July 8, 2020, The U.S. Food and Drug Administration (FDA) announced a voluntary recall by Lupin Pharmaceuticals Inc. (Lupin) for all batches of metformin hydrochloride extended release (ER) 500 mg and 1000mg tablets made by their company.
- On July 13, 2020, The FDA announced a voluntary recall by AvKARE for all batches of metformin hydrochloride extended release (ER) tablets made by their company.
The FDA found that certain batches of metformin hydrochloride ER made by Lupin and AvKARE tested higher than the acceptable daily intake limit levels of NDMA.
Members have been asked to contact the pharmacist who dispensed their medication or the provider who prescribed their medication if their medicine is included in these recalls. Their pharmacist may dispense another metformin product not affected by the
recalls and a new prescription isn’t required. Providers may prescribe an alternative treatment option.
Read the FDA
announcement on the Lupin and AvKARE Metformin recalls for more information.